Samalin Investment Counsel LLC lifted its position in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 17.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 182,351 shares of the financial services provider’s stock after buying an additional 27,735 shares during the period. abrdn Healthcare Investors comprises 1.1% of Samalin Investment Counsel LLC’s holdings, making the stock its 22nd largest position. Samalin Investment Counsel LLC owned 0.32% of abrdn Healthcare Investors worth $3,809,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Sage Capital Advisors llc grew its stake in abrdn Healthcare Investors by 56.4% in the third quarter. Sage Capital Advisors llc now owns 30,848 shares of the financial services provider’s stock valued at $644,000 after acquiring an additional 11,121 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of abrdn Healthcare Investors during the second quarter worth about $149,000. NewEdge Advisors LLC raised its position in shares of abrdn Healthcare Investors by 8.4% during the second quarter. NewEdge Advisors LLC now owns 164,510 shares of the financial services provider’s stock worth $3,616,000 after purchasing an additional 12,772 shares during the period. Ameritas Advisory Services LLC acquired a new stake in shares of abrdn Healthcare Investors during the second quarter worth about $149,000. Finally, Turner Financial Group Inc. acquired a new stake in shares of abrdn Healthcare Investors during the second quarter worth about $388,000. Institutional investors and hedge funds own 32.60% of the company’s stock.
abrdn Healthcare Investors Stock Performance
Shares of HQH opened at $20.27 on Monday. The stock has a 50 day simple moving average of $21.47 and a 200 day simple moving average of $20.88. abrdn Healthcare Investors has a 52-week low of $17.14 and a 52-week high of $24.85.
abrdn Healthcare Investors Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Monday, August 24th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 13.0%. The ex-dividend date was Monday, August 24th.
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE: HQH) is a non-diversified, closed-end investment company focused on the global healthcare and life sciences industries. Rather than operating healthcare businesses directly, the fund invests in the securities of companies involved in areas such as pharmaceuticals, biotechnology, medical devices, healthcare services and related technologies.
The fund seeks long-term capital appreciation, with current income as a secondary objective. Its portfolio may include common and preferred stocks, convertible securities and other investments issued by healthcare companies at various stages of development.
Featured Articles
- Five stocks we like better than abrdn Healthcare Investors
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
